Search research articles
Contact Us
Filters
Showing results (71-80 of 89) with videos related to
Page
of 9
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
April 19, 2021
Advanced genetic engineering to achieve in vivo targeting of adenovirus utilizing camelid single domain antibody
Myungeun Lee, Zhi Hong Lu, Charles B Shoemaker, et al.
Plant Biotechnology Journal
|
September 18, 2014
Algal chloroplast produced camelid VH H antitoxins are capable of neutralizing botulinum neurotoxin
Daniel J Barrera, Julian N Rosenberg, Joanna G Chiu, et al.
Infection and Immunity
|
October 2, 2013
A single VHH-based toxin-neutralizing agent and an effector antibody protect mice against challenge with Shiga toxins 1 and 2
Jacqueline M Tremblay, Jean Mukherjee, Clinton E Leysath, et al.
Plos One
|
January 13, 2012
A novel strategy for development of recombinant antitoxin therapeutics tested in a mouse botulism model
Jean Mukherjee, Jacqueline M Tremblay, Clinton E Leysath, et al.
Infection and Immunity
|
November 5, 2014
Adenovirus vector expressing Stx1/Stx2-neutralizing agent protects piglets infected with Escherichia coli O157:H7 against fatal systemic intoxication
Abhineet S Sheoran, Igor P Dmitriev, Elena A Kashentseva, et al.
The Journal of Biological Chemistry
|
August 27, 2017
Single-domain antibodies pinpoint potential targets within <i>Shigella</i> invasion plasmid antigen D of the needle tip complex for inhibition of type III secretion
Michael L Barta, Jonathan P Shearer, Olivia Arizmendi, et al.
EMBO Molecular Medicine
|
August 11, 2017
mRNA mediates passive vaccination against infectious agents, toxins, and tumors
Moritz Thran, Jean Mukherjee, Marion Pönisch, et al.
Molecular Pharmaceutics
|
November 17, 2015
Identification of Targeting Peptides for Mucosal Delivery in Sheep and Mice
Elisabeth E Kenngott, Sally Cole, Wayne R Hein, et al.
Clinical and Vaccine Immunology : CVI
|
July 15, 2016
A Tetraspecific VHH-Based Neutralizing Antibody Modifies Disease Outcome in Three Animal Models of Clostridium difficile Infection
Diane J Schmidt, Gillian Beamer, Jacqueline M Tremblay, et al.
Nature Communications
|
April 24, 2023
Structural basis for botulinum neurotoxin E recognition of synaptic vesicle protein 2
Zheng Liu, Pyung-Gang Lee, Nadja Krez, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 89) with videos related to
Sort By:
Page
of 9
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
April 19, 2021
Advanced genetic engineering to achieve in vivo targeting of adenovirus utilizing camelid single domain antibody
Myungeun Lee, Zhi Hong Lu, Charles B Shoemaker, et al.
Plant Biotechnology Journal
|
September 18, 2014
Algal chloroplast produced camelid VH H antitoxins are capable of neutralizing botulinum neurotoxin
Daniel J Barrera, Julian N Rosenberg, Joanna G Chiu, et al.
Infection and Immunity
|
October 2, 2013
A single VHH-based toxin-neutralizing agent and an effector antibody protect mice against challenge with Shiga toxins 1 and 2
Jacqueline M Tremblay, Jean Mukherjee, Clinton E Leysath, et al.
Plos One
|
January 13, 2012
A novel strategy for development of recombinant antitoxin therapeutics tested in a mouse botulism model
Jean Mukherjee, Jacqueline M Tremblay, Clinton E Leysath, et al.
Infection and Immunity
|
November 5, 2014
Adenovirus vector expressing Stx1/Stx2-neutralizing agent protects piglets infected with Escherichia coli O157:H7 against fatal systemic intoxication
Abhineet S Sheoran, Igor P Dmitriev, Elena A Kashentseva, et al.
The Journal of Biological Chemistry
|
August 27, 2017
Single-domain antibodies pinpoint potential targets within <i>Shigella</i> invasion plasmid antigen D of the needle tip complex for inhibition of type III secretion
Michael L Barta, Jonathan P Shearer, Olivia Arizmendi, et al.
EMBO Molecular Medicine
|
August 11, 2017
mRNA mediates passive vaccination against infectious agents, toxins, and tumors
Moritz Thran, Jean Mukherjee, Marion Pönisch, et al.
Molecular Pharmaceutics
|
November 17, 2015
Identification of Targeting Peptides for Mucosal Delivery in Sheep and Mice
Elisabeth E Kenngott, Sally Cole, Wayne R Hein, et al.
Clinical and Vaccine Immunology : CVI
|
July 15, 2016
A Tetraspecific VHH-Based Neutralizing Antibody Modifies Disease Outcome in Three Animal Models of Clostridium difficile Infection
Diane J Schmidt, Gillian Beamer, Jacqueline M Tremblay, et al.
Nature Communications
|
April 24, 2023
Structural basis for botulinum neurotoxin E recognition of synaptic vesicle protein 2
Zheng Liu, Pyung-Gang Lee, Nadja Krez, et al.
Page
of 9